Influence of sex steroids on inflammation and bone metabolism

Periodontology 2000

Volumn 64, Issue 1, 2014, Pages 81-94

  Shiau, Harlan J ^a   Aichelmann Reidy, Mary E ^a   Reynolds, Mark A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

AGING; BONE; BONE REMODELING; CHRONIC PERIODONTITIS; DISEASE PREDISPOSITION; FEMALE; HOMEOSTASIS; HUMAN; IMMUNOLOGY; INFLAMMATION; MALE; METABOLISM; PHYSIOLOGY; SEX DIFFERENCE;

AGING; BONE AND BONES; BONE REMODELING; CHRONIC PERIODONTITIS; DISEASE SUSCEPTIBILITY; FEMALE; GONADAL STEROID HORMONES; HOMEOSTASIS; HUMANS; INFLAMMATION; MALE; SEX FACTORS;

EID: 84889688460     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/prd.12033     Document Type: Article

References (150)

1. Abney TO. The potential roles of estrogens in regulating Leydig cell development and function: a review. Steroids 1999: 64: 610-617.
2. Al Habashneh R, Guthmiller JM, Levy S, Johnson GK, Squier C, Dawson DV, Fang Q. Factors related to utilization of dental services during pregnancy. J Clin Periodontol 2005: 32: 815-821.
3. Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, Garcia I. Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 1997: 99: 1699-1703.
4. Amory JK, Anawalt BD, Matsumoto AM, Page ST, Bremner WJ, Wang C, Swerdloff RS, Clark RV. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. J Urol 2008: 179: 2333-2338.
5. Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985: 121: 531-551.
6. Arlt W. Androgen therapy in women. Eur J Endocrinol 2006: 154: 1-11.
7. Audet-Walsh E, Lepine J, Gregoire J, Plante M, Caron P, Têtu B, Ayotte P, Brisson J, Villeneuve L, Bélanger A, Guillemette C. Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics. J Clin Endocrinol Metab 2011: 96: E330-E339.
8. Baser U, Cekici A, Tanrikulu-Kucuk S, Kantarci A, Ademoglu E, Yalcin F. Gingival inflammation and interleukin-1 beta and tumor necrosis factor-alpha levels in gingival crevicular fluid during the menstrual cycle. J Periodontol 2009: 80: 1983-1990.
9. Baulieu EE. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor. Science 1989: 245: 1351-1357.
10. Beato M. Gene regulation by steroid hormones. Cell 1989: 56: 335-344.
11. Bebo BF Jr, Schuster JC, Vandenbark AA, Offner H. Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999: 162: 35-40.
12. Becerik S, Ozcaka O, Nalbantsoy A, Atilla G, Celec P, Behuliak M, Emingil G. Effects of menstrual cycle on periodontal health and gingival crevicular fluid markers. J Periodontol 2010: 81: 673-681.
13. Ben-Hur H, Mor G, Insler V, Blickstein I, Amir-Zaltsman Y, Sharp A, Globerson A, Kohen F. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 1995: 34: 363-369.
14. Berg JM, Tymoczko JL, Stryer L. Biochemistry, 6th edn. New York, NY: W.H. Freeman, 2007.
15. Berry KL, Cameron JD, Dart AM, Dewar EM, Gatzka CD, Jennings GL, Liang YL, Reid CM, Kingwell BA. Large-artery stiffness contributes to the greater prevalence of systolic hypertension in elderly women. J Am Geriatr Soc 2004: 52: 368-373.
16. Bjornerem A, Straume B, Midtby M, Fønnebø V, Sundsfjord J, Svartberg J, Acharya G, Oian P, Berntsen GK. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Tromso Study. J Clin Endocrinol Metab 2004: 89: 6039-6047.
17. Bouman A, Heineman MJ, Faas MM. Sex hormones and the immune response in humans. Hum Reprod Update 2005: 11: 411-423.
18. Bouman A, Schipper M, Heineman MJ, Faas MM. Gender difference in the non-specific and specific immune response in humans. Am J Reprod Immunol 2004: 52: 19-26.
19. Canalis E, Raisz LG. Effect of sex steroids on bone collagen synthesis in vitro. Calcif Tissue Res 1978: 25: 105-110.
20. Cazzaniga M, Bonanni B. Breast cancer chemoprevention: old and new approaches. J Biomed Biotechnol 2012: 2012: 985620.
21. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 2000: 106: 1229-1237.
22. Chin KY, Ima-Nirwana S. Sex steroids and bone health status in men. Int J Endocrinol 2012: 2012: 208719.
23. Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med 1998: 129: 229-240.
24. Civitelli R, Pilgram TK, Dotson M, Muckerman J, Lewandowski N, Armamento-Villareal R, Yokoyama-Crothers N, Kardaris EE, Hauser J, Cohen S, Hildebolt CF. Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2002: 162: 1409-1415.
25. Clarke BL, Khosla S. Androgens and bone. Steroids 2009: 74: 296-305.
26. Clarke CL, Sutherland RL. Progestin regulation of cellular proliferation. Endocr Rev 1990: 11: 266-301.
27. Cooke PS, Buchanan DL, Young P, Setiawan T, Brody J, Korach KS, Taylor J, Lubahn DB, Cunha GR. Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium. Proc Natl Acad Sci USA 1997: 94: 6535-6540.
28. Correale J, Arias M, Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid protein-specific CD4 + T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998: 161: 3365-3374.
29. Crocker IP, Baker PN, Fletcher J. Neutrophil function in pregnancy and rheumatoid arthritis. Ann Rheum Dis 2000: 59: 555-564.
30. De Vries GJ. Sex steroids and sex chromosomes at odds? Endocrinology 2005: 146: 3277-3279.
31. Deitch EA, Livingston DH, Lavery RF, Monaghan SF, Bongu A, Machiedo GW. Hormonally active women tolerate shock-trauma better than do men: a prospective study of over 4000 trauma patients. Ann Surg 2007: 246: 447-453; discussion 453-445.
32. DonCarlos LL, Greene GL, Morrell JI. Estrogen plus progesterone increases progestin receptor immunoreactivity in the brain of ovariectomized guinea pigs. Neuroendocrinology 1989: 50: 613-623.
33. Du JT, Vennos E, Ramey E, Ramwell PW. Sex differences in arachidonate cyclo-oxygenase products in elicited rat peritoneal macrophages. Biochim Biophys Acta 1984: 794: 256-260.
34. Engeland CG, Sabzehei B, Marucha PT. Sex hormones and mucosal wound healing. Brain Behav Immun 2009: 23: 629-635.
35. Engelmann F, Barron A, Urbanski H, Neuringer M, Kohama SG, Park B, Messaoudi I. Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques. Age (Dordr) 2011: 33: 275-289.
36. Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008: 173: 600-609.
37. Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998: 90: 1371-1388.
38. Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001: 22: 564-571.
39. Gao Y, Qian WP, Dark K, Toraldo G, Lin AS, Guldberg RE, Flavell RA, Weitzmann MN, Pacifici R. Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc Natl Acad Sci USA 2004: 101: 16618-16623.
40. Garcia-Duran M, De Frutos T, Diaz-Recasens J, García-Gálvez G, Jiménez A, Montón M, Farré J, Sánchez de Miguel L, González-Fernández F, Arriero MD, Rico L, García R, Casado S, López-Farré A. Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res 1999: 85: 1020-1026.
41. Geisler J, Haynes B, Anker G, Dowsett M, Lonning PE. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 2002: 20: 751-757.
42. Gillgrass AE, Fernandez SA, Rosenthal KL, Kaushic C. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J Virol 2005: 79: 3107-3116.
43. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997: 158: 446-451.
44. Giron-Gonzalez JA, Moral FJ, Elvira J, García-Gil D, Guerrero F, Gavilán I, Escobar L. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000: 143: 31-36.
45. Grassi F, Tell G, Robbie-Ryan M, Gao Y, Terauchi M, Yang X, Romanello M, Jones DP, Weitzmann MN, Pacifici R. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA 2007: 104: 15087-15092.
46. Haas AN, Rosing CK, Oppermann RV, Albandar JM, Susin C. Association among menopause, hormone replacement therapy, and periodontal attachment loss in southern Brazilian women. J Periodontol 2009: 80: 1380-1387.
47. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP. Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res 2000: 15: 710-720.
48. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 1999: 25: 255-259.
49. Hong CH, Napenas JJ, Hodgson BD, Stokman MA, Mathers-Stauffer V, Elting LS, Spijkervet FK, Brennan MT, Dental Disease Section, Oral Care Study Group, Multi-national Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). A systematic review of dental disease in patients undergoing cancer therapy. Support Care Cancer 2010: 18: 1007-1021.
50. Imai Y, Kondoh S, Kouzmenko A, Kato S. Minireview: osteoprotective action of estrogens is mediated by osteoclastic estrogen receptor-alpha. Mol Endocrinol 2010: 24: 877-885.
51. Irwin JC, Kirk D, Gwatkin RB, Navre M, Cannon P, Giudice LC. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 1996: 97: 438-447.
52. Jasnow AM, Schulkin J, Pfaff DW. Estrogen facilitates fear conditioning and increases corticotropin-releasing hormone mRNA expression in the central amygdala in female mice. Horm Behav 2006: 49: 197-205.
53. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006: 17: 1726-1733.
54. Jonsson D, Andersson G, Ekblad E, Liang M, Bratthall G, Nilsson BO. Immunocytochemical demonstration of estrogen receptor beta in human periodontal ligament cells. Arch Oral Biol 2004: 49: 85-88.
55. Kanda N, Tsuchida T, Tamaki K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 1996: 106: 410-415.
56. Kania DM, Binkley N, Checovich M, Havighurst T, Schilling M, Ershler WB. Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc 1995: 43: 236-239.
57. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006: 124: 823-835.
58. Kenny AM, Prestwood KM, Gruman CA, Marcello KM, Raisz LG. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels. J Gerontol A Biol Sci Med Sci 2001: 56: M266-M272.
59. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001: 142: 5050-5055.
60. Khosla S. Update on estrogens and the skeleton. J Clin Endocrinol Metab 2010: 95: 3569-3577.
61. Khosla S, Atkinson EJ, Melton LJ III, Riggs BL. Effects of age and estrogen status on serum parathyroid hormone levels and biochemical markers of bone turnover in women: a population-based study. J Clin Endocrinol Metab 1997: 82: 1522-1527.
62. Kimble RB, Bain S, Pacifici R. The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 1997: 12: 935-941.
63. King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B, National Surgical Adjuvant Breast Bowel Project. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial. JAMA 2001: 286: 2251-2256.
64. Komi J, Lassila O. Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 2000: 95: 2875-2882.
65. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999: 397: 315-323.
66. Kudielka BM, Kirschbaum C. Sex differences in HPA axis responses to stress: a review. Biol Psychol 2005: 69: 113-132.
67. Kuehn BM. Prostate, baldness drugs linked to sexual dysfunction. JAMA 2012: 307: 1903.
68. Kumar RJ, Barqawi A, Crawford ED. Adverse events associated with hormonal therapy for prostate cancer. Rev Urol 2005: 7(Suppl. 5): S37-S43.
69. Kumar V, Green S, Stack G, Berry M, Jin JR, Chambon P. Functional domains of the human estrogen receptor. Cell 1987: 51: 941-951.
70. Lam EW, Shah K, Brosens JJ. The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer. J Endocrinol 2012: 212: 13-25.
71. Lamonte MJ, Hovey KM, Genco RJ, Millen AE, Trevisan M, Wactawski-Wende J. Five-year changes in periodontal disease measures among postmenopausal women. The Buffalo osteoperio study. J Periodontol 2013: 84: 572-584.
72. Latham KA, Zamora A, Drought H, Subramanian S, Matejuk A, Offner H, Rosloniec EF. Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J Immunol 2003: 171: 5820-5827.
73. Leslie CA, Gonnerman WA, Cathcart ES. Gender differences in eicosanoid production from macrophages of arthritis-susceptible mice. J Immunol 1987: 138: 413-416.
74. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009: 20: 477-482.
75. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995: 9: 2266-2278.
76. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol 2009: 30: 366-373.
77. Mamalis A, Markopoulou C, Lagou A, Vrotsos I. Oestrogen regulates proliferation, osteoblastic differentiation, collagen synthesis and periostin gene expression in human periodontal ligament cells through oestrogen receptor beta. Arch Oral Biol 2011: 56: 446-455.
78. Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000: 21: 115-137.
79. Marbaix E, Donnez J, Courtoy PJ, Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci USA 1992: 89: 11789-11793.
80. Mariotti A. Sex steroid hormones and cell dynamics in the periodontium. Crit Rev Oral Biol Med 1994: 5: 27-53.
81. Mariotti A, Mawhinney M. Endocrinology of sex steroid hormones and cell dynamics in the periodontium. Periodontol 2000 2013: 61: 69-88.
82. Marriott I, Huet-Hudson YM. Sexual dimorphism in innate immune responses to infectious organisms. Immunol Res 2006: 34: 177-192.
83. McDonald TW, Annegers JF, O'Fallon WM, Dockerty MB, Malkasian GD Jr, Kurland LT. Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol 1977: 127: 572-580.
84. Mella JM, Perret MC, Manzotti M, Catalano HN, Guyatt G. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review. Arch Dermatol 2010: 146: 1141-1150.
85. Michaels RM, Rogers KD. A sex difference in immunologic responsiveness. Pediatrics 1971: 47: 120-123.
86. Miller AP, Feng W, Xing D, Weathington NM, Blalock JE, Chen YF, Oparil S. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 2004: 110: 1664-1669.
87. Miyagi M, Aoyama H, Morishita M, Iwamoto Y. Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes. J Periodontol 1992: 63: 28-32.
88. Miyaura C, Onoe Y, Inada M, Maki K, Ikuta K, Ito M, Suda T. Increased B-lymphopoiesis by interleukin 7 induces bone loss in mice with intact ovarian function: similarity to estrogen deficiency. Proc Natl Acad Sci USA 1997: 94: 9360-9365.
89. Nair R, Taylor H. The mechanism of menstruation. In: Santoro N, Neal-Perry G, editors. Amenorrhea: a case-based clinical guide. New York, NY: Springer Science+Business Media, LLC, 2010: 21-31.
90. Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc Natl Acad Sci USA 1995: 92: 3650-3657.
91. Natoli AK, Medley TL, Ahimastos AA, Drew BG, Thearle DJ, Dilley RJ, Kingwell BA. Sex steroids modulate human aortic smooth muscle cell matrix protein deposition and matrix metalloproteinase expression. Hypertension 2005: 46: 1129-1134.
92. Norbury R, Cutter WJ, Compton J, Robertson DM, Craig M, Whitehead M, Murphy DG. The neuroprotective effects of estrogen on the aging brain. Exp Gerontol 2003: 38: 109-117.
93. Norderyd OM, Grossi SG, Machtei EE, Zambon JJ, Hausmann E, Dunford RG, Genco RJ. Periodontal status of women taking postmenopausal estrogen supplementation. J Periodontol 1993: 64: 957-962.
94. Nussey S, Whitehead S. Endocrinology: an integrated approach. Oxford: BIOS Scientific Publishers, Ltd., 2001.
95. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet 2008: 9: 911-922.
96. Orwoll ES, Klein RF. Osteoporosis in men. Endocr Rev 1995: 16: 87-116.
97. Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 2005: 23: 1616-1622.
98. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci USA 1994: 91: 10129-10133.
99. Overlie I, Moen MH, Morkrid L, Skjaeraasen JS, Holte A. The endocrine transition around menopause-a five years prospective study with profiles of gonadotropines, estrogens, androgens and SHBG among healthy women. Acta Obstet Gynecol Scand 1999: 78: 642-647.
100. Paavonen T, Andersson LC, Adlercreutz H. Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med 1981: 154: 1935-1945.
101. Pacifici R. Cytokines, estrogen, and postmenopausal osteoporosis-the second decade. Endocrinology 1998: 139: 2659-2661.
102. Paller CJ, Shiels MS, Rohrmann S, Basaria S, Rifai N, Nelson W, Platz EA, Dobs A. Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf) 2009: 70: 26-34.
103. Parsons B, MacLusky NJ, Krey L, Pfaff DW, McEwen BS. The temporal relationship between estrogen-inducible progestin receptors in the female rat brain and the time course of estrogen activation of mating behavior. Endocrinology 1980: 107: 774-779.
104. Pasquali R, Vicennati V, Gambineri A, Pagotto U. Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity. Int J Obes (Lond) 2008: 32: 1764-1779.
105. Payne JB, Reinhardt RA, Nummikoski PV, Patil KD. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women. Osteoporos Int 1999: 10: 34-40.
106. Payne JB, Zachs NR, Reinhardt RA, Nummikoski PV, Patil K. The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol 1997: 68: 24-31.
107. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993: 15: 17-35.
108. Polan ML, Loukides J, Nelson P, Carding S, Diamond M, Walsh A, Bottomly K. Progesterone and estradiol modulate interleukin-1 beta messenger ribonucleic acid levels in cultured human peripheral monocytes. J Clin Endocrinol Metab 1989: 69: 1200-1206.
109. Prior JC. Progesterone as a bone-trophic hormone. Endocr Rev 1990: 11: 386-398.
110. Pritchard K. Endocrinology and hormone therapy in breast cancer: endocrine therapy in premenopausal women. Breast Cancer Res 2005: 7: 70-76.
111. Puck JM, Deschenes SM, Porter JC, Dutra AS, Brown CJ, Willard HF, Henthorn PS. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 1993: 2: 1099-1104.
112. Rachon D, Mysliwska J, Suchecka-Rachon K, Wieckiewicz J, Mysliwski A. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. J Endocrinol 2002: 172: 387-395.
113. Ralston SH. Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994: 9: 883-890.
114. Rannevik G, Jeppsson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1995: 21: 103-113.
115. Reinhardt RA, Payne JB, Maze CA, Patil KD, Gallagher SJ, Mattson JS. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women. J Periodontol 1999: 70: 823-828.
116. Riggs BL, Khosla S, Melton LJ III Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002: 23: 279-302.
117. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R. Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 2001: 98: 13960-13965.
118. Ronderos M, Jacobs DR, Himes JH, Pihlstrom BL. Associations of periodontal disease with femoral bone mineral density and estrogen replacement therapy: cross-sectional evaluation of US adults from NHANES III. J Clin Periodontol 2000: 27: 778-786.
119. Roy BN, Reid RL, Van Vugt DA. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey. Endocrinology 1999: 140: 2191-2198.
120. Russell AS, Johnston C, Chew C, Maksymowych WP. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J Rheumatol 1997: 24: 1045-1050.
121. Sanchez R, Nguyen D, Rocha W, White JH, Mader S. Diversity in the mechanisms of gene regulation by estrogen receptors. BioEssays 2002: 24: 244-254.
122. Sasano H, Uzuki M, Sawai T, Nagura H, Matsunaga G, Kashimoto O, Harada N. Aromatase in human bone tissue. J Bone Miner Res 1997: 12: 1416-1423.
123. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. Gender differences in human sepsis. Arch Surg 1998: 133: 1200-1205.
124. Schuster V, Kreth HW. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein. Immunol Rev 2000: 178: 21-28.
125. Seeman E. Invited review: pathogenesis of osteoporosis. J Appl Physiol 2003: 95: 2142-2151.
126. Siiteri PK, Wilson JD. Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 1974: 38: 113-125.
127. Simpson E, Rubin G, Clyne C, Robertson K, O'Donnell L, Davis S, Jones M. Local estrogen biosynthesis in males and females. Endocr Relat Cancer 1999: 6: 131-137.
128. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003: 86: 225-230.
129. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase expression in health and disease. Recent Prog Horm Res 1997: 52: 185-213; discussion 213-184.
130. Smith SM, Baskin GB, Marx PA. Estrogen protects against vaginal transmission of simian immunodeficiency virus. J Infect Dis 2000: 182: 708-715.
131. Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Holmes JH, Dlewati A, Staley J, Santanna J, Kapoor SC, Attie MF, Haddad JG Jr, Strom BL. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab 1999: 84: 1966-1972.
132. Sperry JL, Frankel HL, Vanek SL, Nathens AB, Moore EE, Maier RV, Minei JP. Early hyperglycemia predicts multiple organ failure and mortality but not infection. J Trauma 2007: 63: 487-493; discussion 493-484.
133. Stefano GB, Peter D. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: therapeutic implications. Med Sci Monit 2001: 7: 1066-1074.
134. Suzuki N, Yano T, Nakazawa N, Yoshikawa H, Taketani Y. A possible role of estrone produced in adipose tissues in modulating postmenopausal bone density. Maturitas 1995: 22: 9-12.
135. Thijssen JH. Local biosynthesis and metabolism of oestrogens in the human breast. Maturitas 2004: 49: 25-33.
136. Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc Natl Acad Sci USA 2003: 100: 125-130.
137. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995: 13: 251-276.
138. Vaananen HK, Zhao H, Mulari M, Halleen JM. The cell biology of osteoclast function. J Cell Sci 2000: 113(Pt 3): 377-381.
139. Van den Beld AW, De Jong FH, Grobbee DE, Pols HA, Lamberts SW. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab 2000: 85: 3276-3282.
140. Van Dyke TE, Hoop GA. Neutrophil function and oral disease. Crit Rev Oral Biol Med 1990: 1: 117-133.
141. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004: 25: 389-425.
142. Wactawski-Wende J, Hausmann E, Hovey K, Trevisan M, Grossi S, Genco RJ. The association between osteoporosis and alveolar crestal height in postmenopausal women. J Periodontol 2005: 76: 2116-2124.
143. Waddell TK, Dart AM, Gatzka CD, Cameron JD, Kingwell BA. Women exhibit a greater age-related increase in proximal aortic stiffness than men. J Hypertens 2001: 19: 2205-2212.
144. Warren DW, Haltmeyer GC, Eik-Nes KB. Testosterone in the fetal rat testis. Biol Reprod 1973: 8: 560-565.
145. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 1993: 14: 353-356.
146. Wei LL, Leach MW, Miner RS, Demers LM. Evidence for progesterone receptors in human osteoblast-like cells. Biochem Biophys Res Commun 1993: 195: 525-532.
147. Weisz A, Cicatiello L, Persico E, Scalona M, Bresciani F. Estrogen stimulates transcription of c-jun protooncogene. Mol Endocrinol 1990: 4: 1041-1050.
148. Weitzmann MN, Roggia C, Toraldo G, Weitzmann L, Pacifici R. Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency. J Clin Invest 2002: 110: 1643-1650.
149. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998: 95: 3597-3602.
150. Ziel HK, Finkle WD. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med 1975: 293: 1167-1170.